Westfield Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Sell |
3,669
-1,356
| -27% | -$146K | ﹤0.01% | 236 |
|
|
2025
Q1 | $507K | Buy |
5,025
+745
| +17% | +$75.2K | ﹤0.01% | 237 |
|
|
2024
Q4 | $382K | Buy |
4,280
+25
| +0.6% | +$2.23K | ﹤0.01% | 231 |
|
|
2024
Q3 | $357K | Buy |
+4,255
| New | +$357K | ﹤0.01% | 244 |
|
|
2022
Q1 | – | Sell |
-81,153
| Closed | -$3.45M | – | 239 |
|
|
2021
Q4 | $3.45M | Sell |
81,153
-1,921,076
| -96% | -$81.6M | 0.02% | 205 |
|
|
2021
Q3 | $86.9M | Buy |
2,002,229
+162,486
| +9% | +$7.05M | 0.52% | 66 |
|
|
2021
Q2 | $78.7M | Sell |
1,839,743
-1,231,876
| -40% | -$52.7M | 0.47% | 77 |
|
|
2021
Q1 | $119M | Sell |
3,071,619
-393,109
| -11% | -$15.2M | 0.74% | 39 |
|
|
2020
Q4 | $125M | Buy |
3,464,728
+462,115
| +15% | +$16.6M | 0.74% | 36 |
|
|
2020
Q3 | $115M | Sell |
3,002,613
-97,538
| -3% | -$3.73M | 0.74% | 40 |
|
|
2020
Q2 | $109M | Buy |
3,100,151
+1,165,267
| +60% | +$40.9M | 0.75% | 40 |
|
|
2020
Q1 | $63.1M | Sell |
1,934,884
-683,750
| -26% | -$22.3M | 0.56% | 57 |
|
|
2019
Q4 | $118M | Buy |
2,618,634
+647,200
| +33% | +$29.3M | 0.84% | 29 |
|
|
2019
Q3 | $80.2M | Buy |
+1,971,434
| New | +$80.2M | 0.64% | 53 |
|